NEW YORK – Fulgent Genetics said on Monday that it has increased its full-year 2020 revenue estimate by nearly 30 percent as a result of growing demand for its COVID-19 testing solutions.
NEW YORK – Fulgent Genetics said on Monday that it has increased its full-year 2020 revenue estimate by nearly 30 percent as a result of growing demand for its COVID-19 testing solutions.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.
Don't have a GenomeWeb or 360Dx account?
Register for Free.
Privacy Policy. Terms & Conditions. . Copyright © 2021 GenomeWeb, a business unit of Crain Communications. All Rights Reserved.